Keyphrases
Breast Cancer
59%
Breast
49%
Breast Reconstruction
40%
Intraoperative Radiation Therapy
29%
Mastectomy
28%
Early Breast Cancer
20%
Sentinel Lymph Node Biopsy
17%
Bryostatin
17%
Postmastectomy Breast Reconstruction
17%
Confidence Interval
17%
Breast Cancer Patients
15%
Tumor
15%
Complication Rate
13%
Immediate Reconstruction
13%
Ductal Breast Carcinoma
12%
Telapristone Acetate
12%
Ionomycin
12%
Neoadjuvant Trials
12%
Phase II Trial
12%
T Cells
11%
Adoptive Immunotherapy
11%
Surgeons
11%
Intraoperative Radiotherapy
11%
Multi-institutional Analysis
11%
TARGIT
11%
Cryopreserved
11%
Activated T Cells
11%
Postmastectomy Radiation Therapy
11%
North America
11%
Ductal Carcinoma in Situ
10%
Tumor-draining Lymph Nodes
10%
Surgical Site Infection
10%
Magnetic Resonance Imaging
10%
Breast Cancer Prevention
10%
Calcium Ionophore
9%
Breast Skin
9%
Transdermal
9%
Lymph Node Cells
9%
Lymphocytes
9%
Patient Outcomes
9%
Radiation Therapy
8%
Tumor-bearing Host
8%
Risk Factors
8%
4-OHT
8%
Tumor Regression
8%
Autologous Tumors
8%
Odds Ratio
7%
Interleukin-2
7%
Comorbidity
7%
Triple Negative
7%
Medicine and Dentistry
Breast Cancer
100%
Mastectomy
41%
Breast Reconstruction
37%
Neoplasm
35%
Intraoperative Radiation Therapy
28%
Surgeon
19%
Radiation Therapy
14%
Magnetic Resonance Imaging
14%
T Cell
13%
In Vitro
13%
Contralateral
13%
Malignant Neoplasm
12%
Recurrent Disease
12%
Quality Improvement
11%
Placebo
11%
Telapristone Acetate
11%
Axillary Lymph Node
11%
Sentinel Lymph Node Biopsy
11%
Estrogen Receptor
11%
Bryostatin
11%
Biopsy Technique
10%
Surgical Infection
9%
Clinical Trial
9%
Comorbidity
9%
Postoperative Complication
9%
Specific Tumor
9%
Lymph Node
8%
Adoptive Immunotherapy
8%
Lumpectomy
8%
Interleukin 2
8%
Calcium Ionophore
7%
Cytotoxic T-Cell
7%
Tumor Regression
7%
Ionomycin
7%
Sentinel Lymph Node
6%
Bryostatin 1
6%
CD8 Antigen
6%
Odds Ratio
6%
Reoperation
6%
Lymphocyte
6%
Breast Surgery
6%
Magnetic Resonance Imaging of Breast
6%
Drug Distribution
5%
Hypopharynx
5%
Lipid Metabolism
5%
Eribulin
5%
Phase II Trials
5%
Cryopreservation
5%
Electronic Cigarette
5%
Homologous Recombination
5%